1. Home
  2. FTFT vs CASI Comparison

FTFT vs CASI Comparison

Compare FTFT & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTFT
  • CASI
  • Stock Information
  • Founded
  • FTFT N/A
  • CASI 1991
  • Country
  • FTFT United States
  • CASI China
  • Employees
  • FTFT N/A
  • CASI N/A
  • Industry
  • FTFT Business Services
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • FTFT Consumer Discretionary
  • CASI Health Care
  • Exchange
  • FTFT Nasdaq
  • CASI Nasdaq
  • Market Cap
  • FTFT 19.7M
  • CASI 20.5M
  • IPO Year
  • FTFT N/A
  • CASI 1996
  • Fundamental
  • Price
  • FTFT $2.50
  • CASI $1.48
  • Analyst Decision
  • FTFT
  • CASI Strong Buy
  • Analyst Count
  • FTFT 0
  • CASI 1
  • Target Price
  • FTFT N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • FTFT 5.2M
  • CASI 80.5K
  • Earning Date
  • FTFT 08-18-2025
  • CASI 08-15-2025
  • Dividend Yield
  • FTFT N/A
  • CASI N/A
  • EPS Growth
  • FTFT N/A
  • CASI N/A
  • EPS
  • FTFT N/A
  • CASI N/A
  • Revenue
  • FTFT $2,031,913.00
  • CASI $31,368,000.00
  • Revenue This Year
  • FTFT N/A
  • CASI N/A
  • Revenue Next Year
  • FTFT N/A
  • CASI N/A
  • P/E Ratio
  • FTFT N/A
  • CASI N/A
  • Revenue Growth
  • FTFT N/A
  • CASI 8.39
  • 52 Week Low
  • FTFT $1.01
  • CASI $1.09
  • 52 Week High
  • FTFT $5.70
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • FTFT 57.54
  • CASI 54.85
  • Support Level
  • FTFT $2.35
  • CASI $1.21
  • Resistance Level
  • FTFT $2.98
  • CASI $1.44
  • Average True Range (ATR)
  • FTFT 0.49
  • CASI 0.11
  • MACD
  • FTFT 0.03
  • CASI 0.03
  • Stochastic Oscillator
  • FTFT 44.36
  • CASI 72.97

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: